Skip to content
Global Access Atlas
Research brief
Public change log

What changed in policy—or in our evidence—and how the pathway changed

Entries distinguish a new external policy event from an Atlas research revision. The official source date and the date Atlas changed its content are always shown separately. The log starts on 6 August 2026; earlier dossier work forms the initial evidence baseline.

Logging since2026-08-06
Saved in this browser. No email alerts or account required.
Atlas updated
Philippines
Pathway changeAtlas research revision
Latest cited official sourceDate not specifiedAtlas content updated2026-10-29

Philippines: updated regulatory, HTA and benefit-delivery references

Why Atlas revised this pathway

Added current CSP rules and dated 2026 HTA/PNDF adoption evidence; clarified GAMOT continuity, inpatient shadow billing and procurement transition. First treatment is separate from later claim settlement.

Change in the Atlas pathway

Use the nine checks as references for the chosen financing context; verify product, patient, provider, contract and stock conditions separately.

Affected access gates
FDA marketing authorisation (CPR)Financing and care-setting contextHTA topic nomination and prioritisationAssessment, preliminary recommendation and appealFinal recommendation and formal adoptionFormulary or named benefit-package implementationPrice and public procurement termsProvider readiness and claim requirementsFirst treatment or dispensing